EP Medsystems Inc - Current report filing (8-K)
March 03 2008 - 5:20PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): February 26, 2008
EP MedSystems, Inc.
(Exact Name of Registrant Specified in Charter)
|
|
|
|
|
New Jersey
|
|
0-28260
|
|
22-32122190
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
575 Route 73 North, Building D
West Berlin, New Jersey
|
|
08091
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code: (856) 753-8533
Not Applicable
(Former Name or
Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02(e). Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.
On February 26, 2008, the Board of Directors of EP MedSystems, Inc. (the Company)
approved senior management incentive agreements (the Senior Management Incentive Agreements) for each of David I. Bruce, the Companys President and Chief Executive Officer, and James J. Caruso, the Companys Chief Financial
Officer (each a Senior Officer). Each Senior Management Incentive Agreement provides for the following:
|
|
|
If either Senior Officer is employed by the Company immediately prior to a change in control of the Company (as defined in each Senior Management Incentive
Agreement), each such Senior Officer will be entitled to a lump sum cash payment in an amount equal to two (2) times his annual base salary (at the rate in effect immediately prior to the date such change in control takes place). Such lump sum
payment will be paid within 10 business days of the date the change in control transaction is consummated.
|
|
|
|
If either Senior Officer is employed by the Company immediately prior to a change in control of the Company, any unvested options to acquire the Companys
common stock held by either Senior Officer will vest immediately prior to the consummation of such change in control. This provision is consistent with the Companys policy, previously approved by the Board of Directors, that all options to
purchase common stock granted to Company employees (including all senior officers) will vest immediately prior to a change of control.
|
|
|
|
Should any of the payments described above (the Incentive Payments) be deemed parachute payments under Section 280G(b)(1) of the
Internal Revenue Code of 1986, as amended, each Senior Officer will be entitled to a gross-up payment (each such payment, a Gross-Up Payment) in an amount equal to (i) any excise tax imposed any Incentive Payment,
(ii) all income, employment and excise taxes imposed upon any Gross-Up Payment and (iii) any interest or penalties imposed with respect to income and employment taxes imposed on any Gross-Up Payment; provided however, that the amount of
all Gross-Up Payments payable to either Senior Officer will not exceed twenty percent (20%) of the aggregate value of the cash payment and accelerated vesting (as described above) to which such Senior Officer is entitled to under his Senior
Management Incentive Agreement.
|
The terms of Mr. Bruces Senior Management Incentive Agreement are consistent with his
employment offer letter, previously disclosed by the Company on Form 8-K filed with the Securities Exchange Commission on August 17, 2006.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
EP MEDSYSTEMS, INC.
|
|
|
|
Date: March 3, 2008
|
|
By:
|
|
/s/ JAMES J. CARUSO
|
|
|
|
|
James J. Caruso
Chief Financial Officer and Secretary
|
EP Medsystems (MM) (NASDAQ:EPMD)
Historical Stock Chart
From Oct 2024 to Nov 2024
EP Medsystems (MM) (NASDAQ:EPMD)
Historical Stock Chart
From Nov 2023 to Nov 2024